Molnlycke Health Care

What Molnlycke Health Care does

Mölnlycke Health Care AB is a Swedish MedTech company founded in 1849 and headquartered in Gothenburg, operating as the largest wholly-owned subsidiary of Investor AB within Patricia Industries. It organises its offering into four business areas — Wound Care (~60% of 2025 sales), Operating Room Solutions, Gloves, and Antiseptics — selling advanced foam dressings (Mepilex, Mepilex Border Post-Op, Mepilex Up), gelling fibre dressings (Exufiber), ProcedurePak custom trays, BARRIER surgical drapes, surgical gowns, Biogel double-gloving systems, and Granudacyn wound cleansing solutions to hospitals, healthcare providers, and procurement organisations in 100+ countries. The portfolio is supported by a digital layer (Flow Companion OR ecosystem, Mölnlycke Portal for tray management) and an LCA/SPPA-based sustainability framework, with proprietary IP evidenced through peer-reviewed clinical studies (ARCTIS for Mepilex Border Post-Op, Journal of Hospital Infection for double-gloving indicator systems).

The company operates nine manufacturing sites across Sweden, Finland, the UK, the Czech Republic, Belgium, the US (Brunswick, Maine), Thailand, Malaysia and China (Changshu under construction), and distributes through a combination of direct B2B sales, country-specific local sites (30+ markets), channel distributors, and majority-owned joint ventures — Tamer Mölnlycke Care (60% stake in Saudi Arabia) and the newly formed Zhende-Mölnlycke JV in China. Revenue is generated through quote-based B2B pricing negotiated with hospital and procurement buyers; FY2023 net sales were EUR 1,924M and 2025 organic growth was 4%. Recent strategic activity includes the 2024 acquisition of P.G.F. Industry Solutions GmbH (Granudacyn), ~EUR 290M of announced capacity expansions (Brunswick, Mikkeli, Oldham, Changshu), and new financing — a EUR 500M 10-year bond (2024), a USD 400M SEK facility (2025), and a EUR 350M revolving credit facility (2023).

Name

Molnlycke Health Care

Legal name

Mölnlycke Health Care AB

Website

https://molnlycke.com

Company type

Private

Founded year

1849

Operating status

Operating

Headcount range

5,001–10,000 employees

Short description

Mölnlycke Health Care is a Swedish MedTech company (founded 1849, Gothenburg) that designs and manufactures wound care dressings, surgical procedure trays, gloves, and antiseptics for hospitals and healthcare providers across 100+ countries, generating ~EUR 1.9B in annual sales.

Ownership category

akta.pro rank

Product category

Medical Devices & Wound Care

NAICS

Surgical Appliance and Supplies Manufacturing (339113), Medical Equipment and Supplies Manufacturing (33911)

SIC

Orthopedic, Prosthetic & Surgical Appliances & Supplies (3842), Specialty Cleaning, Polishing And Sanitation Preparations (2842)

akta.pro primary industry

First Aid & Wound Care (Bandages, Dressings, Antiseptics, Burn Care) (CRADAMAB)

Keywords

• Advanced wound care
• Surgical solutions
• Medical gloves
• Antiseptic solutions
• Operating room supplies

Headquarters

HQ city

Gothenburg

HQ country

Sweden

HQ region

Europe

Offices7 records

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Operations, Supply Chain, Personnel, Technology or R&D, Marketing or Sales, Infrastructure, Others

Revenue model

1. Wound care product sales: Mölnlycke's largest business area, accounting for 60% of total sales (2025). Includes advanced foam dressings (Mepilex), gelling fibre dressings (Exufiber), post-op dressings, and wound cleansing solutions (Granudacyn). Sold to hospitals and healthcare providers globally.
2. Operating Room Solutions (ORS) sales: Single-use surgical solutions including ProcedurePak custom trays, surgical drapes (BARRIER), gowns, and the Flow Companion digital OR ecosystem. Recurring high-volume consumable sales plus digital ecosystem add-ons.
3. Gloves sales: Single-use surgical and examination gloves including Biogel double-gloving systems with indicator breach-detection technology. Sold into hospitals and ORs.
4. Antiseptics sales: Skin-friendly antiseptic products used across the patient journey to reduce infection risk; supported by Mölnlycke's position statements on hazardous substances and infection control.

Pricing tiers

Go-to-market motion4 records

Distribution channels5 records

Marketing channels9 records

Core offering

Mölnlycke Health Care manufactures and sells medical devices and consumables across four business areas: Wound Care (advanced foam, gelling fibre, and post-op dressings), Operating Room Solutions (ProcedurePak custom trays, surgical drapes, gowns), Gloves (single-use surgical and examination gloves with double-gloving indicator systems), and Antiseptics. Products are sold primarily to hospitals, healthcare providers, and procurement organisations worldwide, complemented by digital ecosystem tools for the OR.

Product overview

Mölnlycke Health Care offers a portfolio-based MedTech platform organised around four business areas — Wound Care (the largest, ~60% of 2025 sales), Operating Room Solutions, Gloves, and Antiseptics — rather than a single unified SaaS-style product. The portfolio combines physical medical devices (e.g., Mepilex Border Post-Op and Mepilex Up advanced foam dressings, Exufiber, Mepilex Border Flex, Granudacyn wound cleansing solutions, ProcedurePak custom trays, BARRIER surgical drapes, and PRIMARY Plus surgical gowns) with digital/AI-enabled capabilities such as the Flow Companion OR ecosystem and the Mölnlycke Portal for tray management, plus educational services via the Clinical Learning Hub. Together, these offerings cover the patient journey from wound prevention (e.g., pressure injury management) and surgical procedure support to post-operative care, burn treatment, VLU/DFU management, and infection prevention, with sustainability positioned as a cross-cutting platform attribute.

Differentiator

Problem solved

Functional benefit

Brands

• Granudacyn: Range of solutions for wound cleansing and moisturising, originally from P.G.F. Industry Solutions GmbH, acquired in 2024.
• Mölnlycke ProcedurePak
• Mepilex
• Mölnlycke Flow Companion
• BARRIER

Products and services

• Mölnlycke Wound Care Largest business area offering innovative wound care products and therapy-based solutions for hospitals and healthcare providers across pressure injury management, incision care, burn treatment, venous leg ulcer management, diabetic foot ulcer management, and wound cleansing.
• Mölnlycke Operating Room Solutions Ecosystem of solutions for improved and sustainable ways of working in the operating room, including surgical drapes, gowns, custom trays, and digital solutions supporting frictionless OR flow.
• Mölnlycke Gloves Innovative and sustainable surgical and examination glove solutions including double-gloving solutions and indicator systems that reduce the risk of undetected glove breaches during surgery.
• Mölnlycke Antiseptics Skin-friendly antiseptic products effective on microbes with long lasting effect, supporting skin integrity and reducing the potential of infections across the patient journey.
• Mepilex Border Post-Op Advanced post-operative foam dressing clinically proven to be safely used for up to 14 days after surgery, designed to minimise dressing-related waste and greenhouse gas emissions associated with disposal.
• Mepilex Up Innovative foam dressing designed for exuding wounds, featured on Mölnlycke's corporate homepage as a new launch.
• Granudacyn Range of solutions for wound cleansing and moisturising acquired via P.G.F. Industry Solutions GmbH in 2024; used for wound irrigation and to keep wounds moist, helping loosen bandages and dressings.
• ProcedurePak Customisable single-use OR trays consolidating surgical components and supplies; switching from single-packed supplies to ProcedurePak trays can reduce packing waste by up to 90% and save preparation time.
• Flow Companion Digital ecosystem of solutions for the operating room, originating from ethnographic research and grown into an incubator for Mölnlycke's broader digital portfolio including the Mölnlycke Portal for tray management.
• Mölnlycke Portal Online portal for managing ProcedurePak trays and reducing the environmental impact of OR workflows, cited as an example of digital solutions enabling customers to reduce their own emissions and material use.
• BARRIER surgical drapes Range of surgical drapes; the first range was launched in 2021 with demonstrable reductions in emissions.
• PRIMARY Plus high performance surgical gown Comfortable multi-purpose high-performance surgical gown within Mölnlycke's OR Solutions portfolio.
• Exufiber Wound dressing highlighted as an example of innovation in Mölnlycke's R&D portfolio; a gelling fibre dressing that absorbs, spreads and holds fluid.
• Mepilex Border Flex Advanced foam dressing featured within Mölnlycke's innovation and R&D portfolio.

Quantifiable outcome

• Up to 90% reduction in packing waste by switching to ProcedurePak custom trays vs single-packed supplies
• +10 more outcomes

Segments4 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Integration4 records

AI capability6 records

Feature7 records

Partnerships

16 partnerships are on record, tiered flagship, core and minor.

• Zhende MedicalflagshipStrategic or Co-development Partner · 21 May 2026Formed a new majority-owned joint venture in China announced 21 May 2026 to accelerate growth in one of the world's fastest-growing wound care markets. The JV will integrate both companies' wound care portfolios and commercial capabilities to offer healthcare providers, patients and the public expanded access to advanced treatments, with operations expected to start in Q3 2026.
• Swedish National Climate Initiative (Healthcare & Life Science)coreStrategic or Co-development Partner · 3 February 2026Joined a broad public-private National Climate Initiative for the Swedish healthcare and life science sector (announced 3 February 2026) to accelerate the green transition and achieve net-zero emissions across the entire healthcare value chain by 2045. Involves over 20 organisations including pharmaceutical companies, pharmacy chains, regional healthcare authorities, and industry associations.
• MedTech Europe (Wound Care Sector Working Group)flagshipStrategic or Co-development Partner · 1 December 2025Mölnlycke elected one of the organisations leading the Wound Care Sector Working Group at MedTech Europe (announced 1 December 2025), the industry association representing medical technology across the continent. Co-authored white paper 'Shaping the future of wound care in Europe' urging EU policymakers to prioritise wound care.
• Wound Care Collaborative Community (WCCC)coreStrategic or Co-development Partner · 2 May 2025Supports the Wound Care Collaborative Community initiative announced May 2025, a groundbreaking effort to develop a standardised pre-clinical testing framework for wound dressings. Mölnlycke is a participating industry partner in the collaborative.
• TransdiagencoreStrategic or Co-development Partner · 24 October 2024Research collaboration announced 24 October 2024 to drive innovation in wound care. The partnership focuses on next-generation therapeutic approaches leveraging Transdiagen's scientific platform.
• Ondine BiomedicalcoreStrategic or Co-development Partner · 23 September 2024Announced 23 September 2024 that Mölnlycke and Ondine joined forces against healthcare-associated infections (HAIs), leveraging Ondine's Steriwave photodisinfection technology alongside Mölnlycke's wound care and infection prevention portfolio.
• Phoenix Society for Burn SurvivorscoreGTM or Marketing Partner · 17 May 2024Partnership announced 17 May 2024 with Phoenix Society for Burn Survivors, a US-based patient advocacy organisation for the burns community. Supports Mölnlycke's mission in burn care and patient advocacy.
• Tamer Group (Tamer Mölnlycke Care JV)flagshipStrategic or Co-development Partner · 15 May 2024Joint venture in the Kingdom of Saudi Arabia with Tamer Group, the market leader in healthcare distribution in KSA. Mölnlycke expanded its stake from 33.3% to 60% on 15 May 2024 to become majority shareholder, expanding operations in the Middle East. The JV was certified ISO 14001 and ISO 45001 in May 2025.
• P.G.F. Industry Solutions GmbHflagshipStrategic or Co-development Partner · 12 April 2024Acquisition completed 1 October 2024; P.G.F. is the Austrian manufacturer of Granudacyn® wound cleansing and moisturising solutions. Agreement to acquire was announced 12 April 2024 to expand Mölnlycke's wound care business, with distribution in over 50 countries. ISO 45001 certification planned for the Austrian site in 2026.
• Operation SmileflagshipGTM or Marketing Partner · 1 January 2004Long-term charity partner since 2004 supporting Operation Smile, which provides free cleft lip and cleft palate (CLP) repair surgery for children in regions where access to healthcare is difficult. Most recent milestone: inauguration of the Comprehensive Cleft Centre of Excellence in Cebu, Philippines in 2024, expected to serve 10,000 patients in three years.
• CAISR (Center for Applied Intelligent Systems Research), Halmstad University, SwedencoreStrategic or Co-development PartnerPre-competitive strategic partnership with CAISR - a research profile with information-driven care at Halmstad University. Uses real-world patient data from Region Halland in Sweden to explore how AI can help improve patient trajectories.
• International Hospital FederationcoreStrategic or Co-development PartnerGlobal partnership with the International Hospital Federation as part of Mölnlycke's healthcare professional organisation engagement programme; results include co-developed thought leadership such as the Non-Value Report 2025.
• AdvaMed, APACMed and other regional trade associationscoreStrategic or Co-development PartnerActive engagement with regional trade associations including AdvaMed (US) and APACMed (Asia-Pacific) to advocate for Value-Based Health Care and shape MedTech policy across regions.
• SedexcoreTechnology or IntegrationMölnlycke is a Sedex member using the Sedex risk assessment approach to screen all new and active suppliers. Aligned with SMETA 4-pillar audit methodology for ethical and social performance in global supply chains.
• Ignite SwedenminorGTM or Marketing PartnerEngages with Ignite Sweden's startup incubator through around 30 annual matchmaking events; awarded the Ignite Rising Star award.
• YunctureminorGTM or Marketing PartnerCollaborates with Yuncture, an incubator for young entrepreneurs, to develop innovative concepts connected to the surgical flow.

Scale indicators17 records

Recent moves11 records

Expansion highlights8 records

Direct peers

• Smith+Nephew: Global MedTech with Advanced Wound Management, Orthopaedics, and Sports Medicine franchises. Smith+Nephew is the most directly comparable peer to Mölnlycke, competing head-to-head in foam dressings (ALLEVYN), gelling fibres, and negative pressure wound therapy across the same hospital procurement channels.
• ConvaTec: Specialist wound care and ostomy company publicly listed in the UK. ConvaTec competes directly with Mölnlycke in advanced wound dressings (Aquacel hydrofibre), hospital consumables, and chronic wound management, with overlapping customer base among hospitals and home health providers.
• Coloplast: Danish MedTech specialist in ostomy, continence, wound care, and skin care. Coloplast's Wound Care business is a direct peer to Mölnlycke's largest (~60%) business area, with comparable Biatain foam/superabsorbent dressings and similar hospital and patient/caregiver channels.
• B. Braun: German family-owned MedTech and pharmaceutical company with surgical, wound care, and infection prevention divisions. B. Braun competes with Mölnlycke in surgical drapes/gowns, OR custom trays, and IV/fluid management, sharing the European hospital procurement ecosystem.
• Paul Hartmann: German MedTech company focused on wound care, incontinence, and surgical/disinfection solutions. Hartmann competes directly with Mölnlycke in advanced wound dressings (Hydrocoll, PermaFoam) and OR consumables, primarily across European and emerging markets.

Broad incumbents

• 3M Health Care / Solventum: Solventum (spun off from 3M in 2024) operates a broad MedTech portfolio including advanced wound care (3M Tegaderm, Cavilon) and surgical solutions. Comparable to Mölnlycke across both wound care and OR consumables, with larger scale and broader portfolio breadth but less focus on the European hospital segment.
• Johnson & Johnson MedTech (Ethicon): J&J's MedTech division (including Ethicon) is a global leader in surgical sutures, wound closure, and OR solutions. Direct overlap with Mölnlycke's OR Solutions franchise in drapes, gowns, and procedural consumables; broad incumbent advantage across IDN/GPO contracts.
• Cardinal Health: US-listed medical products distributor and MedTech manufacturer with significant wound care, surgical, and hospital consumables portfolios. Overlaps with Mölnlycke in surgical gowns, drapes, gloves and procedure trays sold through similar IDN/GPO channels.
• Medline Industries: Large privately-held US medical products manufacturer and distributor with leading positions in surgical gloves, drapes, gowns, and advanced wound care. Medline directly competes with Mölnlycke's Gloves, OR Solutions and Wound Care franchises, particularly in North American hospital channels.

Emerging players

• Getinge: Swedish-listed MedTech company with surgical workflows, infection control, and ICU/OR integration solutions. Partial overlap with Mölnlycke's OR Solutions and digital Flow Companion efforts; Getinge brings stronger OR integration/health-IT capabilities but smaller wound care portfolio.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat7 records

Key risks7 records

Key highlights7 records

Customer concentration

• YouTubeyoutube.com/channel/UCkX2zRNf977jBQZ2AwXOkVA
• Facebookfacebook.com/molnlycke
• LinkedInlinkedin.com/company/m-lnlycke-health-care
• Instagraminstagram.com/molnlyckehealthcare
• Xx.com/molnlyckehc

Compliance10 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles13 records

Subsidiaries4 records

Funding overview

Funding rounds2 records

Investors1 record

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A8 records

Investments3 records

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Molnlycke Health Care